Kishor Mayekar

Array ( [id] => 4159942 [patent_doc_number] => 06114520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => '5\'-deoxy-cytidine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/484174 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13851 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114520.pdf [firstpage_image] =>[orig_patent_app_number] => 484174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316824 [patent_doc_number] => 06242591 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Synthesis of sulfurized 2\'-substituted oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/481486 [patent_app_country] => US [patent_app_date] => 2000-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6168 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242591.pdf [firstpage_image] =>[orig_patent_app_number] => 481486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1359943 [patent_doc_number] => 06573247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Anti-viral pyrimidine nucleoside analogues' [patent_app_type] => B1 [patent_app_number] => 09/403853 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9105 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 350 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573247.pdf [firstpage_image] =>[orig_patent_app_number] => 09403853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420740 [patent_doc_number] => 06194598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Aminooxy-modified oligonucleotide synthetic intermediates' [patent_app_type] => 1 [patent_app_number] => 9/477902 [patent_app_country] => US [patent_app_date] => 2000-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 30152 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194598.pdf [firstpage_image] =>[orig_patent_app_number] => 477902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1275470 [patent_doc_number] => 06649750 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Process for the preparation of oligonucleotide compounds' [patent_app_type] => B1 [patent_app_number] => 09/477878 [patent_app_country] => US [patent_app_date] => 2000-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13957 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649750.pdf [firstpage_image] =>[orig_patent_app_number] => 09477878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636279 [patent_doc_number] => 06380380 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Use of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucliotide phosphate (NADP) analogs to measure enzyme activities metabolites and substrates' [patent_app_type] => B1 [patent_app_number] => 09/475736 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5810 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380380.pdf [firstpage_image] =>[orig_patent_app_number] => 09475736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1308426 [patent_doc_number] => 06617438 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Oligoribonucleotides with enzymatic activity' [patent_app_type] => B1 [patent_app_number] => 09/476387 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 39649 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617438.pdf [firstpage_image] =>[orig_patent_app_number] => 09476387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413938 [patent_doc_number] => 06528640 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Synthetic ribonucleic acids with RNAse activity' [patent_app_type] => B1 [patent_app_number] => 09/474432 [patent_app_country] => US [patent_app_date] => 1999-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 38883 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528640.pdf [firstpage_image] =>[orig_patent_app_number] => 09474432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360072 [patent_doc_number] => 06255294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Cyanocobalamin (vitamin B12) treatment in allergic disease' [patent_app_type] => 1 [patent_app_number] => 9/473332 [patent_app_country] => US [patent_app_date] => 1999-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3987 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255294.pdf [firstpage_image] =>[orig_patent_app_number] => 473332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294420 [patent_doc_number] => 06235892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Process for the purification of nucleic acids' [patent_app_type] => 1 [patent_app_number] => 9/468706 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2028 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235892.pdf [firstpage_image] =>[orig_patent_app_number] => 468706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1308408 [patent_doc_number] => 06617437 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Pyrimidine derivatives for labeled binding partners' [patent_app_type] => B1 [patent_app_number] => 09/468454 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12111 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617437.pdf [firstpage_image] =>[orig_patent_app_number] => 09468454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1337358 [patent_doc_number] => 06593306 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Methods for modulation and inhibition of telomerase' [patent_app_type] => B1 [patent_app_number] => 09/467932 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21381 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593306.pdf [firstpage_image] =>[orig_patent_app_number] => 09467932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1462790 [patent_doc_number] => 06350736 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Aryl phosphate derivatives of d4T having anti-HIV activity' [patent_app_type] => B1 [patent_app_number] => 09/464516 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 9479 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350736.pdf [firstpage_image] =>[orig_patent_app_number] => 09464516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1545741 [patent_doc_number] => 06444652 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => '-L-2\'-deoxy-nucleosides for the treatment of hepatitis B' [patent_app_type] => B1 [patent_app_number] => 09/459150 [patent_app_country] => US [patent_app_date] => 1999-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17437 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444652.pdf [firstpage_image] =>[orig_patent_app_number] => 09459150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248860 [patent_doc_number] => 06221851 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Pharmaceutical therapy for congestive heart failure' [patent_app_type] => 1 [patent_app_number] => 9/454569 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 43 [patent_no_of_words] => 18017 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221851.pdf [firstpage_image] =>[orig_patent_app_number] => 454569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4382729 [patent_doc_number] => 06294522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'N6 heterocyclic 8-modified adenosine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/454485 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9804 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294522.pdf [firstpage_image] =>[orig_patent_app_number] => 454485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1319197 [patent_doc_number] => 06605597 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Partial or full A1agonists-N-6 heterocyclic 5-thio substituted adenosine derivatives' [patent_app_type] => B1 [patent_app_number] => 09/454136 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10268 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605597.pdf [firstpage_image] =>[orig_patent_app_number] => 09454136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260790 [patent_doc_number] => 06258793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'N6 heterocyclic 5\' modified adenosine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/454436 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 19078 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258793.pdf [firstpage_image] =>[orig_patent_app_number] => 454436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463217 [patent_doc_number] => 06350863 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => '3, 4-di(acylamino)phenyl ribofuranosides, 2\'-deoxyribofuranosides, and methods of making' [patent_app_type] => B1 [patent_app_number] => 09/448596 [patent_app_country] => US [patent_app_date] => 1999-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4539 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350863.pdf [firstpage_image] =>[orig_patent_app_number] => 09448596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565346 [patent_doc_number] => 06339074 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Sulfated hyaluronic acid and esters thereof' [patent_app_type] => B1 [patent_app_number] => 09/447429 [patent_app_country] => US [patent_app_date] => 1999-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7934 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339074.pdf [firstpage_image] =>[orig_patent_app_number] => 09447429 [rel_patent_id] =>[rel_patent_doc_number] =>)